Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 9 January 2026

Vertiv stock rebounds after Thursday slide as jobs data steadies rate-cut bets

Vertiv stock rebounds after Thursday slide as jobs data steadies rate-cut bets

New York, Jan 9, 2026, 15:12 EST — Regular session Shares of Vertiv Holdings Co rose 1.5% to $163.24 in afternoon trading on Friday, clawing back some ground after a sharp drop in the prior session. The data center power-and-cooling supplier fell 6.3% on Thursday, a swing that left the stock nursing losses after a tech-led pullback in U.S. equities ahead of the monthly jobs report. (Investing.com) That matters now because Vertiv trades like a rate-sensitive growth name: when investors lean toward interest-rate cuts, high-multiple infrastructure suppliers tend to catch a bid. Broader U.S. indexes were higher on Friday after
9 January 2026
····
KLA stock jumps after Cantor target hike as investors eye Jan. 29 earnings (KLAC)

KLA stock jumps after Cantor target hike as investors eye Jan. 29 earnings (KLAC)

New York, January 9, 2026, 15:03 EST — Regular session KLA Corp shares rose about 5.6% to $1,398.71 in afternoon trading on Friday, tracking a rebound in chip names and fresh bullish analyst comments on the semiconductor equipment cycle. KLA said on Thursday it will review second-quarter fiscal 2026 earnings on Jan. 29 and publish results the same day after the U.S. stock market closes, alongside a shareholder letter and earnings slide deck. (KLA Corporation) The move matters because KLA sits in the middle of a tight trade: investors want exposure to chip spending tied to advanced manufacturing, but they
9 January 2026
·····
Why Abercrombie & Fitch stock is sliding today despite a UBS target hike

Why Abercrombie & Fitch stock is sliding today despite a UBS target hike

New York, Jan 9, 2026, 14:54 EST — Regular session Abercrombie & Fitch shares fell about 3.7% to $125.09 in afternoon trading on Friday, after swinging between $133.16 and $124.17. The drop came as investors digested a weaker-than-expected U.S. jobs report that pulled attention back to the health of the consumer — and the path for interest rates. “Hiring is still stuck in stall speed,” said Olu Sonola, head of U.S. economic research at Fitch Ratings, after payrolls rose 50,000 in December; the report also showed job losses in retail and left expectations intact for the Federal Reserve to hold
9 January 2026
·····
Nebius (NBIS) stock ticks up as AI names rebound — Rubin rollout and earnings are the next tests

Nebius (NBIS) stock ticks up as AI names rebound — Rubin rollout and earnings are the next tests

NEW YORK, Jan 9, 2026, 15:16 EST — Regular session Nebius Group N.V. shares were up 1.2% at $98.48 on Friday afternoon, paring earlier gains after the stock briefly climbed above $104. The Nasdaq-listed shares have ranged from $97.25 to $104.94 in the session. The move came as U.S. stocks pushed higher, with the S&P 500 hitting a record high as chipmakers led broad gains after a weaker-than-expected jobs report, Reuters reported. “On the overall AI theme, investors are getting granular and picking the winners and losers in terms of sub-themes and individual names,” said Zachary Hill, head of portfolio
9 January 2026
·····
Scorpio Tankers stock slips as BofA downgrade revives “peak rates” debate

Scorpio Tankers stock slips as BofA downgrade revives “peak rates” debate

New York, Jan 9, 2026, 14:45 EST — Regular session Shares of Scorpio Tankers Inc fell about 2.3% on Friday after Bank of America Securities cut its rating on the product tanker operator, pointing to signs the freight market may be closer to a top. The stock was down $1.32 at $54.86 in afternoon trading. The call matters because tanker stocks can move fast when analysts start leaning the other way on day rates, which drive earnings for many shipping owners. Scorpio’s shares had climbed in recent sessions, leaving less room for disappointment when the next set of rate and
9 January 2026
····
Texas Instruments stock ticks up as chipmakers rally — what could move TXN next

Texas Instruments stock ticks up as chipmakers rally — what could move TXN next

New York, Jan 9, 2026, 14:59 EST — Regular session Texas Instruments stock (TXN.O) rose about 1% to $190.24 in afternoon trading on Friday. Chipmakers led the gains, with the Philadelphia Semiconductor Index — a gauge of major U.S. chip stocks — up 2.6%, helping lift the S&P 500 to a record high. Broadcom gained 3.7% and Lam Research jumped 8% after Mizuho lifted its price target; “investors are getting granular and picking the winners and losers in terms of sub-themes and individual names,” said Zachary Hill, head of portfolio management at Horizon Investments. (Reuters) A Labor Department report showed
9 January 2026
········
Constellation Energy stock jumps as TD Cowen turns bullish, Meta nuclear deals lift power names

Constellation Energy stock jumps as TD Cowen turns bullish, Meta nuclear deals lift power names

New York, January 9, 2026, 14:44 EST — Regular session Constellation Energy Corp shares were up 5.6% at $340.51 in afternoon trading on Friday, extending a sharp rally in U.S. power producers as investors latched onto new long-term demand signals and a fresh bullish call on the stock. The move matters because the market is treating reliable generation — especially nuclear and flexible gas plants — as scarce again. Data centers and new industrial loads are pushing utilities and generators back into the spotlight, and investors are paying up for companies that can sign long-term contracts. Constellation sits in the
9 January 2026
·······
Coca-Cola stock rises as soft U.S. jobs report boosts staples; CPI, Fed and earnings ahead

Coca-Cola stock rises as soft U.S. jobs report boosts staples; CPI, Fed and earnings ahead

NEW YORK, Jan 9, 2026, 2:44 PM EST — Regular session Coca-Cola (KO) shares rose 1.4% to $70.33 in afternoon trading on Friday, pushing back above the $70 mark as investors leaned into consumer-staples names. The stock traded between $69.11 and $70.41 in the session. The move matters now because rate expectations are doing the work again. U.S. stocks pushed to a record high on Friday after a weaker jobs report, keeping the focus on whether the Federal Reserve can ease later this year without seeing inflation flare again. (Reuters) Nonfarm payrolls — the monthly count of jobs added outside
9 January 2026
····
HealthEquity stock slides after Goldman Sachs downgrade; HQY earnings watch shifts to March

HealthEquity stock slides after Goldman Sachs downgrade; HQY earnings watch shifts to March

New York, Jan 9, 2026, 14:28 EST — Regular session Shares of Nasdaq-listed HealthEquity (HQY) fell 2.9% to $95.64 in afternoon trade on Friday after Goldman Sachs cut its rating to sell from neutral and set an $89 price target. The stock hit a session low of $92.97 before it pared some of the drop. (GuruFocus) The downgrade lands at a touchy moment for the name: the Goldman analyst argued 2026 may bring a “return to normalized patterns” where organic growth — growth without acquisitions — drives how investors price the stock. He also warned the valuation multiple, the price
9 January 2026
·····
P&G stock edges up after Crest kids toothpaste deal; TD Cowen trims target ahead of Jan. 22 earnings

P&G stock edges up after Crest kids toothpaste deal; TD Cowen trims target ahead of Jan. 22 earnings

New York, Jan 9, 2026, 14:56 EST — Regular session Procter & Gamble (PG) shares were up 0.3% at $141.92 Friday afternoon. The consumer-products company agreed to tweak packaging and marketing for Kid’s Crest children’s toothpaste after Texas Attorney General Ken Paxton pushed it to show the “appropriate amount” for kids. New packaging started rolling out on Jan. 1, and P&G has to stay in compliance for five years, Paxton’s office said. (Texas Attorney General) P&G said it was “fully committed to delivering safe, reliable products” and agreed to make sure its artwork matches recommended dosing levels for children. Paxton
9 January 2026
·····
Nuvation Bio stock falls as UBS starts coverage; NUVB investors eye JPM conference next week

Nuvation Bio stock falls as UBS starts coverage; NUVB investors eye JPM conference next week

New York, Jan 9, 2026, 14:36 (EST) — Regular session Nuvation Bio Inc (NUVB) shares slid about 4.7% to $8.05 Friday afternoon, after earlier hitting a session low of $8.05. The stock’s pullback follows new sell-side takes on a name that’s been re-rated since shifting into the commercial stage. UBS started coverage at Neutral with a $10 price target. RBC, meanwhile, lifted its target to $9 from $8 and maintained an Outperform rating, calling the stock “speculative risk.” (MarketScreener) UBS analyst Michael Yee said the bigger picture is starting to turn, arguing biotech “fundamentals are now inflecting” as investor confidence
9 January 2026
···
AST SpaceMobile stock snaps back near $100 as BofA lifts target after Scotiabank cut

AST SpaceMobile stock snaps back near $100 as BofA lifts target after Scotiabank cut

NEW YORK, Jan 9, 2026, 14:40 (EST) — Regular session AST SpaceMobile shares rose 8.6% to $98.34 in Friday afternoon trading after Bank of America raised its price target on the space-based broadband company to $100 from $85 and kept a Neutral rating. (TipRanks) The rebound follows a sharp pullback earlier this week, a reminder of how fast sentiment can swing on the stock. Scotiabank analyst Andres Coello cut AST SpaceMobile to Sector Underperform — roughly a sell — and put a $45.60 price target on it, saying the valuation had climbed to “irrational levels” even though the company has
9 January 2026
·····
1 … 671 672 673 674 675 … 1,918

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
Go toTop